CAS 307519-88-6 appears in our catalog under these names: NMDI14/ 99.37% (existing batch purity), NMDI14, NMDI14 98%, NMDI14, 99.37% ,, 99.37% ,, NMDI14, 99.76%. Offered by: TargetMol, GLPBio, Ambeed, Chemat, MedChemExpress. Available pack sizes: 1mg, 2mg, 5mg, 10mg, 25mg, 50mg, 100mg, 10mM (in 1ml dmso).
NMDI14 is a quinoxaline derivative that is 6,7-dimethyl-1,2,3,4-tetrahydroquinoxaline substituted by 2-{[3-(ethoxycarbonyl)-4,5-dimethylthiophen-2-yl]amino}-2-oxoethyl and oxo groups at positions 2 and 3, respectively. It is a nonsense-mediated mRNA decay (NMD) inhibitor. It is a secondary carboxamide, an ethyl ester, a member of thiophenes and a quinoxaline derivative.
Source: ChEBI
| Molecular formula | C21H25N3O4S |
|---|---|
| Molecular weight | 415.5 g/mol |
| IUPAC name | ethyl 2-[[2-(6,7-dimethyl-3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)acetyl]amino]-4,5-dimethylthiophene-3-carboxylate |
| InChIKey | QRLPSNLBUMVXBL-UHFFFAOYSA-N |
| SMILES | CCOC(=O)C1=C(SC(=C1C)C)NC(=O)CC2C(=O)NC3=C(N2)C=C(C(=C3)C)C |
Computed by PubChem (NCBI)